Skip to main content
NXGL
NASDAQ Life Sciences

NEXGEL Q1 Revenue Falls 5.6%, Loss Per Share Widens to $(0.11)

Tom Rudovsky · Reported by Wiseek News
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.542
Mkt Cap
$6.198M
52W Low
$0.531
52W High
$2.89
52W Position info
2.1% above low
Off High info
81% below high
Rel. Volume info
0.3× avg
Market data snapshot near publication time

NXGL is trading near its 52-week low of $0.531 (2.1% above the low) on light trading volume (0.3× avg).

Summary

NEXGEL, INC. reported a challenging first quarter for 2026, with revenue declining 5.6% year-over-year to $2.65 million. The company's financial performance worsened, as diluted loss per share expanded to $(0.11) from $(0.09) in the prior year's quarter, and net loss attributable to stockholders increased to $(0.927) million. This negative earnings report follows recent board appointments and an amended 10-K, but represents new, material financial information. The deteriorating top-line and bottom-line results are highly significant for a small-cap company already trading near its 52-week low. Traders will closely watch for any signs of stabilization in revenue and progress towards profitability in upcoming quarters, particularly given the focus on expanding consumer channels and developing proprietary medical devices.

At the time of this announcement, NXGL was trading at $0.54 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6.2M. The 52-week trading range was $0.53 to $2.89. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

NXGL - Latest Insights

NXGL
Nov 18, 2026, 5:24 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $3.50
Real-time Price: $3.07 info
Change: -$0.430 (-12%) info
Market Cap: $9.741M info
NXGL
Nov 13, 2026, 9:59 PM EST
Filing Type: 4
Importance Score:
8
Price at Filing: $3.87
Real-time Price: $3.07 info
Change: -$0.800 (-21%) info
Market Cap: $9.741M info
NXGL
Nov 13, 2026, 9:20 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $3.39
Real-time Price: $3.07 info
Change: -$0.320 (-9%) info
Market Cap: $9.741M info
NXGL
Nov 12, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $4.40
Real-time Price: $3.07 info
Change: -$1.33 (-30%) info
Market Cap: $9.741M info
NXGL
Nov 11, 2026, 9:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $3.58
Real-time Price: $3.07 info
Change: -$0.510 (-14%) info
Market Cap: $9.741M info